Today REVIFAST®CARDIO was presented to all pharmaceutical representatives, the new product by S&R Farmaceutici is the brainchild of its Research and Development Division and will further enrich the Company's extensive treatment offering.
The innovative results of
S&R Farmaceutici research
Barely a year on from its début on the pharmaceutical market, S&R Farmaceutici is ready to launch 2 new and highly innovative products stemming from the work of its Research and Development Division...
The expansion plan abroad of S&R Farmaceutici is now under way: the company is successfully concluding the first part of its foreign market penetration plan, thanks to the definition of agreements with important distributors of the sector.
The CME Course "VAGINAL INFECTIONS AND ANAEMIA IN GYNAECOLOGY AND OBSTETRICS" came to a close a few days ago and took place at the new Minerva Auditorium of S&R Farmaceutici.
Dr. Bernard Fioretti together with his collaborator Dr. Francesco Ragonese participated in the course “Bioinformatics for everyone and everything: genomics, epigenomics, transcriptomics” which took place in Udine from 28th June until 1st July 2016 at the University of Udine...